跳至主要内容
临床试验/ISRCTN47442783
ISRCTN47442783进行中(未招募)3 期

AZTEC (Azithromycin Therapy for Chronic Lung Disease of Prematurity) follow up studies: AZTEC@1 and AZTEC@2

Cardiff University0 个研究点目标入组 500 人开始时间: 2022年4月12日最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
500

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36131325/ (added 22/09/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Participation in the AZTEC trial
  • 2. Survival at 36 weeks PCA
  • 3. Consent provided by the parents/guardians to be contacted for follow-up at one and two years of corrected age

排除标准

  • 1. Withdrawal from AZTEC
  • 2. Parents/guardians did not provide consent to follow up at one and two years corrected age
  • 3. Death prior to 36 weeks’ PCA
  • 4. Survival not confirmed

研究者

相似试验

Follow up at 1 and 2 years of corrected age for... | 临床试验